Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 3/20 | 0.49 |
| ▸ | SSTR5 | P35346 | 3/20 | 0.49 |
| ▸ | BCHE | P06276 | 3/20 | 0.48 |
| ▸ | ACHE | P22303 | 3/20 | 0.48 |
| ▸ | UGCG | Q16739 | 7/20 | 0.42 |
| ▸ | GBA2 | Q9HCG7 | 7/20 | 0.42 |
| ▸ | GBA1 | P04062 | 6/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | LCT | P09848 | 4/20 | 0.37 |
| ▸ | SI | P14410 | 3/20 | 0.37 |
| ▸ | MGAM | O43451 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7036444 | 0.97 | BCHE (0.48) | SSTR4SSTR5BCHEACHEUGCG | |
| SCHEMBL29447969 | 0.89 | SSTR4 (0.55) | SSTR4SSTR5BCHEACHEUGCG | |
| SCHEMBL15721072 | 0.89 | SSTR4 (0.55) | SSTR4SSTR5BCHEACHEUGCG | |
| SCHEMBL15721150 | 0.88 | SSTR4 (0.49) | SSTR4SSTR5BCHEACHEUGCG | |
| SCHEMBL15721124 | 0.86 | BCHE (0.50) | SSTR4SSTR5BCHEACHEUGCG | |
| SCHEMBL15721065 | 0.86 | SSTR4 (0.53) | SSTR4SSTR5BCHEACHEUGCG | |
| SCHEMBL15095203 | 0.86 | BCHE (0.51) | SSTR4SSTR5BCHEACHEPDE4D | |
| SCHEMBL17243613 | 0.85 | SSTR4 (0.50) | SSTR4SSTR5BCHEACHEUGCG | |
| SCHEMBL19575247 | 0.85 | SSTR4 (0.50) | SSTR4SSTR5BCHEACHEUGCG | |
| SCHEMBL20577640 | 0.85 | SSTR4 (0.50) | SSTR4SSTR5BCHEACHEUGCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10774043-B2 | Glycolactam compounds, process for preparation and uses thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2020-09-15 | — | — | US | disclosed |
| US-20190194133-A1 | GLYCOLACTAM COMPOUNDS, PROCESS FOR PREPARATION AND USES THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10774043-B2 | Glycolactam compounds, process for preparation and uses thereof | GMNN, C9, OGFR | SSTR4 233/4885SSTR5 276/4885BCHE 52/4885 |
| US-20190194133-A1 | GLYCOLACTAM COMPOUNDS, PROCESS FOR PREPARATION AND USES THEREOF | GALNT14, GALNT10, GALNT3 | SSTR4 115/4885SSTR5 139/4885BCHE 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.